🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Noah Graham

Dana-Farber Cancer Institute

ORCID: 0009-0009-0622-683X
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 15 papers. Top paper: “Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211)”.

Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211)

Journal of Clinical Oncology(2022)10.1200/jco.22.01013
N/A
4.9DataRank · unranked
297 citations

Noah Graham, Paul J. Catalano, Halla Nimeiri, George A. Fisher, Teri A. Longacre +14 more

Importance of Low- and Moderate-Grade Adverse Events in Patients' Treatment Experience and Treatment Discontinuation: An Analysis of the E1912 Trial

Journal of Clinical Oncology(2023)10.1200/jco.23.00377
N/A
2.3DataRank · unranked
46 citations

Fengmin Zhao, Ju‐Whei Lee, Edward H. Ip, John Devin Peipert, Noah Graham +11 more

Patient-Reported Adverse Events and Early Treatment Discontinuation Among Patients With Multiple Myeloma

JAMA Network Open(2024)10.1001/jamanetworkopen.2024.3854
N/A
0.864DataRank · unranked
21 citations

Fengmin Zhao, Ju‐Whei Lee, Shu-en Shen, Edward H. Ip, Nathaniel S. O’Connell +12 more

Examining allostatic load, neighborhood socioeconomic status, symptom burden and mortality in multiple myeloma patients

Blood Cancer Journal(2022)10.1038/s41408-022-00648-y
N/A
0.489DataRank · unranked
25 citations

Noah Graham, Shaji Kumar, Ju‐Whei Lee, Susanna Jacobus, Matthias Weiss +12 more

A phase II/III study of peri-operative nivolumab (nivo) and ipilimumab (ipi) in patients (pts) with locoregional esophageal (E) and gastroesophageal junction (GEJ) adenocarcinoma: Results of the neoadjuvant pathologic complete response (pCR) rate (ECOG-ACRIN EA2174).

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.4000
N/A
0.477DataRank · unranked
23 citations

Noah Graham, Michael K. Gibson, Lakshmi Rajdev, Anuradha Chakravarthy, Onkar V. Khullar +13 more

A randomized study of temozolomide or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors: Final analysis of efficacy and evaluation of MGMT (ECOG-ACRIN E2211).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.4004
N/A
0.464DataRank · unranked
21 citations

Noah Graham, Paul J. Catalano, Halla Nimeiri, George A. Fisher, Teri A. Longacre +15 more

EA2183: A phase III study of consolidative radiotherapy in patients with oligometastatic HER2-negative esophageal and gastric adenocarcinoma.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps4162
N/A
0.272DataRank · unranked
3 citations

Noah Graham, Lakshmi Rajdev, Michael K. Gibson, George A. Fisher, Steven H. Lin +3 more

Tolerability of bevacizumab and chemotherapy in a phase 3 clinical trial with human epidermal growth factor receptor 2–negative breast cancer: A trajectory analysis of adverse events

Cancer(2021)10.1002/cncr.33992
N/A
0.266DataRank · unranked
4 citations

Santiago Saldana, Kathy D. Miller, Ruth C. Carlos, Ilana F. Gareen, Joseph A. Sparano +9 more

Inflammatory cytokines and distant recurrence in HER2-negative early breast cancer in the ECOG-ACRIN 5103 trial.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.520
N/A
0.165DataRank · unranked
2 citations

Anne O’Neill, Noah Graham, Donald W. Northfelt, Chau T. Dang, Antonio C. Wolff +3 more

Overall side‐effect bother consistently associated with early treatment discontinuation due to adverse events in four clinical trials with various cancer types and treatments

Cancer(2025)10.1002/cncr.70084
N/A
0.165DataRank · unranked
2 citations

Shaili Ganatra, Fengmin Zhao, Ju‐Whei Lee, Jessica Roydhouse, Edward H. Ip +13 more

Novel use of alternate (Alt) response (Rp) criteria (Cr) for early prediction of outcomes in pancreatic (P) neuroendocrine tumors (NETs): Utilizing banked imaging data from the ECOG-ACRIN E2211 study.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.4133
N/A
0DataRank · unranked
0 citations

Elizabeth A. Handorf, Pamela L. Kunz, Emel Alkım, Lauren M. Burke, Paul J. Catalano +10 more

Predictive value of baseline patient-rated treatment bother for early anastrozole discontinuation in a racially diverse cohort: Results from ECOG-ACRIN E1Z11.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.12094
N/A
0DataRank · unranked
0 citations

John Devin Peipert, Vered Stearns, Victor T. Chang, Opeyemi A. Jegede, Edward H. Ip +15 more

Phase I study of ribociclib (CDK4/6 inhibitor) with spartalizumab (PD-1 inhibitor) with and without fulvestrant in metastatic hormone receptor-positive breast cancer or advanced ovarian cancer

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2024-010430
N/A
0DataRank · unranked
14 citations

Noah Graham, Lestat R. Ali, Christina I. Herold, Jennifer Desrosiers, Khanh Do +13 more

Association between allostatic load, symptom burden and mortality in E1A11 trial for myeloma.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.12102
N/A
0DataRank · unranked
0 citations

Noah Graham, Shaji Kumar, Ju‐Whei Lee, David Cella, Fengmin Zhao +9 more

Inflammatory cytokines and distant recurrence in HER2-negative early breast cancer

npj Breast Cancer(2022)10.1038/s41523-021-00376-9
N/A
0DataRank · unranked
27 citations

Anne O’Neill, Noah Graham, Donald W. Northfelt, Chau T. Dang, Antonio C. Wolff +3 more